Neuroscience

Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
-   B2262 AgomelatineSummary: MT1/MT2 / 5-HT2C agonist B2262 AgomelatineSummary: MT1/MT2 / 5-HT2C agonist
-   B7409 AstemizoleSummary: anti-histamine compound, potent B7409 AstemizoleSummary: anti-histamine compound, potent
-   B6897 DMeOBSummary: Negative allosteric modulator of mGlu5 B6897 DMeOBSummary: Negative allosteric modulator of mGlu5
-   B7019 Ro 10-5824 dihydrochlorideSummary: dopamine D4 receptor partial agonist B7019 Ro 10-5824 dihydrochlorideSummary: dopamine D4 receptor partial agonist
-   C5591 Indomethacin N-octyl amideSummary: potent but non-selective inhibitor of both COX-1 and COX-2 C5591 Indomethacin N-octyl amideSummary: potent but non-selective inhibitor of both COX-1 and COX-2
-   B2261 ZolmitriptanSummary: Potent 5-HT1B/1D/1F agonist B2261 ZolmitriptanSummary: Potent 5-HT1B/1D/1F agonist
-   B6896 DCBSummary: Allosteric ligand for mGlu5 B6896 DCBSummary: Allosteric ligand for mGlu5
-   B6981 ABT 724 trihydrochlorideSummary: Dopamine D4 receptor agonist,potent and selective B6981 ABT 724 trihydrochlorideSummary: Dopamine D4 receptor agonist,potent and selective
-   B7077 VUF 8430 dihydrobromideSummary: histamine H4 receptor full agonist B7077 VUF 8430 dihydrobromideSummary: histamine H4 receptor full agonist
-   C5581 O-Acetyl Salicylhydroxamic AcidSummary: irreversible, non-selective inhibitor of COX-1 and COX-2 C5581 O-Acetyl Salicylhydroxamic AcidSummary: irreversible, non-selective inhibitor of COX-1 and COX-2
